Feasibility, Challenges, and Benefits of Global Antimicrobial Resistance Surveillance System Implementation: Results from a Multicenter Quasi-Experimental Study
Authors:
- Rujipas SirijatuphatRSRujipas Sirijatuphat
- Sunee ChayangsuSCSunee Chayangsu
- Jintana SrisompongJSJintana Srisompong
- Darat RuangkriengsinDRDarat Ruangkriengsin
- Visanu ThamlikitkulVTVisanu Thamlikitkul
- Surapee TiengrimSTSurapee Tiengrim
- Walaiporn WangchindaWWWalaiporn Wangchinda
- Pornpan KoomanachaiPKPornpan Koomanachai
- Pinyo RattanaumpawanPinyo Rattanaumpawan
Open Access
- 6 March 2022
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 11 (3) , 348
Abstract
The Global Antimicrobial Resistance Surveillance System (GLASS) is one of the pillars of the global action plan on antimicrobial resistance launched by the World Health Organization in 2015. This study was conducted to determine the feasibility and benefits of GLASS as a component of antimicrobial stewardship strategies in three provincial hospitals in Thailand. Data on the types of bacteria isolated and their antibiotic susceptibility during January–December 2019 and January–April 2020 were retrieved from the microbiology laboratory of each participating hospital. Laboratory-based antibiograms from 2019 and GLASS-based antibiograms from 2020 were created and compared. A total of 14,877 and 3580 bacterial isolates were obtained during January–December 2019 and January–April 2020, respectively. The common bacteria isolated in both periods were Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus. Hospital-acquired infection (HAI)-related bacteria were observed in 59.0%, whereas community-acquired infection (CAI)-related bacteria were observed in 41.0% of isolates. Antibiotic resistance in CAIs was high and may have been related to the misclassification of colonized bacteria as true pathogens and HAIs as CAIs. The results of this study on AMR surveillance using GLASS methodology may not be valid owing to several inadequate data collections and the problem of specimen contamination. Given these considerations, related personnel should receive additional training on the best practices in specimen collection and the management of AMR surveillance data using the GLASS approach.Keywords
Funding Information
- Health System Research Thailand (HSR 62-045)
This publication has 13 references indexed in Scilit:
- Effect of the COVID‐19 Pandemic on Laboratory and Clinical Research: A Testimony and a Call to Action From ResearchersHemaSphere, 2020
- Impact of coronavirus syndromes on physical and mental health of health care workers: Systematic review and meta-analysisJournal of Affective Disorders, 2020
- Implementation of global antimicrobial resistance surveillance system (GLASS) in patients with bacteriuriaJournal of Global Antimicrobial Resistance, 2020
- Measuring and mapping the global burden of antimicrobial resistanceBMC Medicine, 2018
- Implementation of global antimicrobial resistance surveillance system (GLASS) in patients with bacteremiaPLOS ONE, 2018
- PREVALENCE AND ANTIBIOTIC SUSCEPTIBLITY OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS, COLLECTED AT THAMMASAT UNIVERSITY HOSPITAL, THAILAND, AUGUST 2012 - JULY 2015.2017
- Epidemiology and economic impact of health care–associated infections and cost-effectiveness of infection control measures at a Thai university hospitalAmerican Journal of Infection Control, 2017
- Poor adherence to guidelines for preventing central line-associated bloodstream infections (CLABSI): results of a worldwide surveyAntimicrobial Resistance & Infection Control, 2016
- Epidemiology of Antibiotic Use and Antimicrobial Resistance in Selected Communities in Thailand.2016
- Epidemiology of Staphylococcus aureus infections and the prevalence of infection caused by community-acquired methicillin-resistant Staphylococcus aureus in hospitalized patients at Siriraj Hospital.2006